Cheap Hearing Aids Work Far Better When an Expert Helps You Fit Them

Over-the-counter hearing aids were supposed to be a revolution: inexpensive amplification devices that anyone with mild to moderate hearing loss could buy, fit themselves, and start using the same day. The promise was access. In much of the world, audiologists are scarce, hearing tests are expensive, and the gap between people who need hearing help and people who get it is enormous. But a nagging question has shadowed the over-the-counter movement since regulators first opened the market: does a device bought off a shelf, tuned by an untrained user, actually deliver the benefit that professionally fitted hearing aids do? A large new randomized trial from China now offers one of the clearest answers yet, and the result is a strikingly nuanced one.

The study, published in Nature Communications, enrolled 322 adults aged 50 or older with untreated bilateral hearing loss across ten community health centers in three Chinese cities: Jinan, Guangzhou, and Ürümqi. Participants were randomly assigned in equal numbers to one of three groups. The first received over-the-counter hearing aids and fitted them entirely on their own. The second received the same devices but with structured support from a primary care physician. The third received remote support from a professional audiologist, delivered through a telefitting platform. Outcome assessors and the trial statisticians were masked to group assignment, a design feature that strengthens confidence in the comparisons. The trial was registered with the Chinese Clinical Trial Registry under identifier ChiCTR2400086117.

The primary outcome was measured with the Abbreviated Profile of Hearing Aid Benefit, a validated questionnaire that captures how much a hearing aid improves everyday listening situations, from quiet conversation to noisy environments. At three months, the differences between the groups were unambiguous. Both supported models outperformed self-fitting by margins that were both statistically robust and clinically meaningful. Remote audiologist support produced an adjusted mean difference of 12.20 points over self-fitting, with a 95 percent confidence interval of 7.18 to 17.22. Primary care physician support produced a difference of 9.71 points, with a confidence interval of 4.74 to 14.67. In hearing research, differences of this size on this scale represent improvements that patients and their families would notice in daily life.

Crucially, the advantage of supported fitting was not confined to a single questionnaire. The trial also measured hearing-related quality of life, user satisfaction, speech recognition performance, and the consistency with which participants actually used their devices. On all of these measures, the supported groups fared better than the self-fitting group. That pattern matters because it addresses a common criticism of single-outcome trials: if support only improved a self-reported score, skeptics could argue the effect was psychological. Here, an objective behavioral measure, speech recognition, moved in the same direction as the subjective reports, and device use itself was higher among supported participants, suggesting the benefit was not merely an artifact of expectation.

The durability of the effect is perhaps the most important finding for policy. The differences between supported and self-fitting groups persisted at twelve months, meaning the benefit of professional or physician involvement was not a short-lived novelty effect that faded once the initial enthusiasm wore on. Hearing aid abandonment is a notorious problem in audiology; many people who acquire devices stop wearing them within the first year, often because the devices were never properly tuned to their hearing loss or their listening environments. A support model that sustains benefit across a full year speaks directly to that failure mode.

Safety is always a central concern when medical devices are moved out of clinical settings, and the trial monitored adverse events carefully. One participant in the self-fitting group died of a stroke, an event the investigators did not attribute to the intervention. No intervention-related serious adverse events occurred in any arm. For a device class that critics worried might be misused or cause harm when fitted without supervision, the safety record in this trial is reassuring, though it is worth noting that participants in all arms received some baseline screening as part of enrollment in a controlled study.

The economic analysis adds a dimension that most hearing aid trials omit, and it may prove to be the most influential part of the paper for health systems. At twelve months, the incremental cost per quality-adjusted life-year gained was 167.16 US dollars for the primary care physician support model and 361.17 US dollars for remote audiologist support. To put those numbers in perspective, health economists generally consider interventions costing less than one to three times a country’s gross domestic product per capita to be highly cost-effective; these figures are orders of magnitude below any conventional threshold. Even the more expensive remote-support model delivered quality-adjusted life-years at a cost that most health systems, including those in low- and middle-income countries, could readily absorb.

The trial’s pragmatic design deserves attention from anyone interpreting the results. Rather than recruiting participants through specialty clinics and delivering care in idealized conditions, the investigators embedded the study in ordinary community health centers, the kind of frontline facilities where older adults actually seek care in China. The physician-support arm did not require an audiologist at all, which is significant because audiologists are concentrated in urban specialty hospitals even in wealthy countries. If a community physician with structured protocols can deliver fitting support that comes within roughly two and a half points of remote audiologist support on the primary benefit measure, the model could be scaled through existing primary care infrastructure rather than requiring an expensive expansion of the audiology workforce.

The remote-support arm also carries implications for how telehealth might reshape hearing care. Audiologists guided the fitting process remotely using a dedicated telefitting platform, meaning that specialist expertise was projected into community settings without patients traveling to specialty clinics. In countries with vast rural populations, or in aging societies where mobility limitations make clinic visits burdensome, remote audiology support paired with over-the-counter devices could close much of the treatment gap. The trial’s finding that remote support produced the largest benefit difference, 12.20 points over self-fitting, suggests that when specialist input is available at a distance, it is worth deploying.

There are, of course, boundaries around what this single trial can establish. The study was conducted in China, and the organization of its primary care system, the specific devices used, and the cultural context of hearing care may not translate identically to other settings. The devices were donated for the research at a discounted rate by the China Aging Development Foundation, and one of the co-authors is employed by the company that developed the remote fitting platform, though the authors report that this entity had no role in study design, data collection, analysis, or the decision to publish. The participants all had untreated bilateral hearing loss, and results might differ for people with more severe losses or complex ear disease, who still require in-person medical evaluation. Still, the core message is difficult to escape: over-the-counter hearing aids are not a fully self-service product for most older adults. The devices work, and they work safely, but pairing them with even modest structured support, whether from a community physician or a remote audiologist, substantially amplifies the benefit, and does so at a cost so low that the real question is no longer whether health systems can afford to provide support, but whether they can afford not to.

Subject of Research: Effectiveness and cost-effectiveness of supported versus self-fitting over-the-counter hearing aids in older adults

Article Title: A randomized trial of supported versus self-fitting over-the-counter hearing aids in older adults

Article References: Jiang, F., Chen, S., Dayimu, A., Gopinath, B., Dong, Q., Jayakody, D. M. P., Wang, S., Jia, Y., Ssemata, A. S., Opondo, C., Louw, Q., Shang, S., Yao, Y., Fu, X., Wang, H., Feng, J., Zhang, H., & Xu, L. (2026). A randomized trial of supported versus self-fitting over-the-counter hearing aids in older adults. Nature Communications. https://doi.org/10.1038/s41467-026-78833-x

Image Credits: AI Generated

DOI: 10.1038/s41467-026-78833-x

Keywords: over-the-counter hearing aids, hearing loss, randomized controlled trial, audiology, telehealth, primary care, older adults, cost-effectiveness, hearing aid fitting, geriatrics, quality of life, hearing rehabilitation